STAA Staar Surgical Co

  1. Stocks
  2. Healthcare
  3. NASDAQ: STAA

Price (delayed)

$27.79

Market cap

$1.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.42

Enterprise value

$1.29B

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 75
Relative Valuation: Rel. Valuation: 14
Relative Profitability: Rel. Profitability: 46

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are ...

Highlights
Staar Surgical's net income has soared by 74% from the previous quarter and by 70% YoY
Staar Surgical's EPS has surged by 74% QoQ and by 71% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.staar.com
Peers: COO ABT IRIX NVS

Key stats

What are the main financial stats of STAA

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
-1.28%
1 week
-10.96%
1 month
-2.46%
1 year
58.26%
YTD
20.36%
QTD
-3.14%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$290.38M
Gross profit
$223.27M
Operating income
-$26.33M
Net income
-$21.03M
Gross margin
76.9%
Net margin
-7.2%
Staar Surgical's net margin has soared by 79% from the previous quarter and by 72% YoY
Staar Surgical's operating margin has soared by 76% from the previous quarter and by 63% YoY
Staar Surgical's net income has soared by 74% from the previous quarter and by 70% YoY
STAA's operating income has surged by 71% since the previous quarter and by 61% year-on-year

Price vs fundamentals

How does STAA's price correlate with its fundamentals

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
STAA P/E details
P/E
N/A
P/B
3.9
P/S
4.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.44
Staar Surgical's EPS has surged by 74% QoQ and by 71% YoY
STAA's price to book (P/B) is 48% lower than its 5-year quarterly average of 7.5 but 26% higher than its last 4 quarters average of 3.1
Staar Surgical's equity has increased by 2.4% QoQ
The stock's price to sales (P/S) is 46% less than its 5-year quarterly average of 8.9 but 6% more than its last 4 quarters average of 4.5
The revenue has grown by 21% from the previous quarter and by 4% YoY

Efficiency

How efficient is Staar Surgical business performance
Staar Surgical's return on sales has surged by 81% QoQ and by 70% YoY
The ROIC has soared by 76% from the previous quarter and by 62% YoY
The ROE has soared by 74% from the previous quarter and by 66% YoY
Staar Surgical's return on assets has surged by 74% QoQ and by 67% YoY

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
STAA's quick ratio is up by 16% QoQ and by 4.7% YoY
The current ratio has grown by 13% from the previous quarter and by 7% YoY
Staar Surgical's debt is 89% less than its equity
The company's debt to equity rose by 10% YoY
Staar Surgical's debt has decreased by 2.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.